Does AMIVANTAMAB Cause Infusion related reaction? 62 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 62 reports of Infusion related reaction have been filed in association with AMIVANTAMAB (Rybrevant). This represents 8.3% of all adverse event reports for AMIVANTAMAB.
62
Reports of Infusion related reaction with AMIVANTAMAB
8.3%
of all AMIVANTAMAB reports
8
Deaths
26
Hospitalizations
How Dangerous Is Infusion related reaction From AMIVANTAMAB?
Of the 62 reports, 8 (12.9%) resulted in death, 26 (41.9%) required hospitalization, and 7 (11.3%) were considered life-threatening.
Is Infusion related reaction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMIVANTAMAB. However, 62 reports have been filed with the FAERS database.
What Other Side Effects Does AMIVANTAMAB Cause?
Rash (61)
Pulmonary embolism (41)
Dermatitis acneiform (34)
Thrombocytopenia (33)
Paronychia (29)
Diarrhoea (25)
Pneumonitis (24)
Dyspnoea (23)
Nausea (23)
Neutropenia (23)
What Other Drugs Cause Infusion related reaction?
INFLIXIMAB (12,946)
RITUXIMAB (11,871)
TOCILIZUMAB (8,340)
METHOTREXATE (7,225)
ADALIMUMAB (6,865)
ABATACEPT (6,759)
PREDNISONE (6,481)
LEFLUNOMIDE (6,205)
HYDROXYCHLOROQUINE (5,991)
ETANERCEPT (5,960)
Which AMIVANTAMAB Alternatives Have Lower Infusion related reaction Risk?
AMIVANTAMAB vs AMIVANTAMAB-VMJW
AMIVANTAMAB vs AMLODIPINE
AMIVANTAMAB vs AMLODIPINE BESILATE
AMIVANTAMAB vs AMLODIPINE\ATORVASTATIN
AMIVANTAMAB vs AMLODIPINE\BENAZEPRIL